Literature DB >> 438844

Neutralizing antibodies to canine distemper and measles virus in multiple sclerosis.

S D Cook, P C Dowling, W C Russell.   

Abstract

Serum neutralizing antibody to canine distemper virus (CDV) was measured in 142 patients with multiple sclerosis (MS), an equal number of age and sex-matched normal controls, and 75 patients with other neurological disorders. An elevated antibody titer was found in the MS population compared to controls. Measles-neutralizing antibody was also found to be elevated in 128 patients with MS. The mean ratio of measles to CDV antibody was similar in the control and MS groups, but a wide range of measles to CDV ratios was found in individual patients and controls. No significant correlation was found between IgG levels and neutralizing antibody titers in MS sera. While the increased titer of measles and CDV antibody may represent a non-specific immunological response, these findings are also consistent with the hypothesis that CDV or a closely related measles virus may stimulate the increased level of measles and CDV antibodies found in MS sera.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 438844     DOI: 10.1016/0022-510x(79)90140-0

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  8 in total

1.  Multiple sclerosis in the Orkney and Shetland Islands. II: The search for an exogenous aetiology.

Authors:  D C Poskanzer; J L Sheridan; L B Prenney; A M Walker
Journal:  J Epidemiol Community Health       Date:  1980-12       Impact factor: 3.710

2.  Sequence homology within the morbilliviruses.

Authors:  S Rozenblatt; O Eizenberg; R Ben-Levy; V Lavie; W J Bellini
Journal:  J Virol       Date:  1985-02       Impact factor: 5.103

3.  Early and late HHV-6 gene transcripts in multiple sclerosis lesions and normal appearing white matter.

Authors:  Margaret L Opsahl; Peter G E Kennedy
Journal:  Brain       Date:  2005-01-19       Impact factor: 13.501

Review 4.  Abnormalities of serum and plasma components in patients with multiple sclerosis.

Authors:  H C Ford
Journal:  Clin Biochem       Date:  1985-02       Impact factor: 3.281

5.  Potential role of paramyxoviruses in multiple sclerosis.

Authors:  S D Cook; B Blumberg; P C Dowling
Journal:  Neurol Clin       Date:  1986-02       Impact factor: 3.806

Review 6.  Experimental models of virus-induced demyelination of the central nervous system.

Authors:  M C Dal Canto; S G Rabinowitz
Journal:  Ann Neurol       Date:  1982-02       Impact factor: 10.422

7.  Evidence for multiple sclerosis as an infectious disease.

Authors:  S D Cook; C Rohowsky-Kochan; S Bansil; P C Dowling
Journal:  Acta Neurol Scand Suppl       Date:  1995

8.  Can viral envelope glycolipids produce auto-immunity, with reference to the CNS and multiple sclerosis?

Authors:  H E Webb; J K Fazakerley
Journal:  Neuropathol Appl Neurobiol       Date:  1984 Jan-Feb       Impact factor: 8.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.